NasdaqGS - Nasdaq Real Time Price USD

LivaNova PLC (LIVN)

Compare
50.75 -0.48 (-0.94%)
At close: September 20 at 4:00 PM EDT
50.75 0.00 (0.00%)
After hours: September 20 at 4:20 PM EDT
Loading Chart for LIVN
DELL
  • Previous Close 51.23
  • Open 51.08
  • Bid 50.74 x 100
  • Ask 50.81 x 100
  • Day's Range 50.31 - 51.15
  • 52 Week Range 42.75 - 64.47
  • Volume 776,926
  • Avg. Volume 684,492
  • Market Cap (intraday) 2.756B
  • Beta (5Y Monthly) 1.00
  • PE Ratio (TTM) --
  • EPS (TTM) -0.31
  • Earnings Date Oct 30, 2024 - Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 71.89

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

www.livanova.com

2,900

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LIVN

View More

Performance Overview: LIVN

Trailing total returns as of 9/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LIVN
1.91%
S&P 500
19.55%

1-Year Return

LIVN
11.43%
S&P 500
28.32%

3-Year Return

LIVN
38.80%
S&P 500
28.64%

5-Year Return

LIVN
35.70%
S&P 500
89.66%

Compare To: LIVN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LIVN

View More

Valuation Measures

Annual
As of 9/20/2024
  • Market Cap

    2.76B

  • Enterprise Value

    3.10B

  • Trailing P/E

    --

  • Forward P/E

    20.88

  • PEG Ratio (5yr expected)

    0.46

  • Price/Sales (ttm)

    2.28

  • Price/Book (mrq)

    2.22

  • Enterprise Value/Revenue

    2.57

  • Enterprise Value/EBITDA

    325.29

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -1.37%

  • Return on Assets (ttm)

    3.34%

  • Return on Equity (ttm)

    -1.34%

  • Revenue (ttm)

    1.21B

  • Net Income Avi to Common (ttm)

    -16.59M

  • Diluted EPS (ttm)

    -0.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    329.24M

  • Total Debt/Equity (mrq)

    54.53%

  • Levered Free Cash Flow (ttm)

    132.39M

Research Analysis: LIVN

View More

Company Insights: LIVN

Research Reports: LIVN

View More

People Also Watch